Table 3.

Treatment-adverse events

Adverse events ↓/CTCAE Grade*→	Grade 1	Grade 2	Grade 3	Grade 4
During/after salvage PRRT in number of NET patients
Nausea	4 (18%)	0	0	0
Vomiting	2 (9%)	0	0	0
Anemia	15 (68.3)	3 (13.5%)	0	0
Leucopenia	2 (9%)	0	0	0
Thrombocytopenia	5 (22.7%)	1 (4.5%)	0	0
Nephrotoxicity	2 (9%)	2 (9%)	0	0
Hepatotoxicity	0	0	0	0

CTCAE, Common Terminology Criteria for Adverse Events; NET, neuroendrocine tumor; PRRT, peptide receptor radionuclide therapy.